OmniSeq Logo

OmniSeq

About - OmniSeq

Who is OmniSeq?

Our global oncology-specific expertise helps advance cancer diagnostics, drugs and devices through the full drug development continuum with speed and efficiency. We’ve designed our oncology team and resources to help you every step of the way—always working to advance patient care. We provide powerful data and advanced technologies to inform preclinical decisions and oncology model selection; design, manage and recruit for clinical trials; leverage appropriate decentralized techniques; generate ongoing real-world evidence; and perform long-term follow-up studies to support the ongoing development of your product. Welcome to your Labcorp Oncology subscription center, where you can update your contact information, the areas that interest you, and about the specialties you work in. Advancements in oncology are just a click away. From innovative technologies and more inclusive clinical trials to improved access to diagnostic testing, discover how we're democratizing cancer care. We have expanded our offerings with the addition of PGDx, a provider of kitted comprehensive liquid biopsy and tissue-based products and services that broaden access on a global scale. We believe healthcare should be determined by a patient’s genetic code, not their zip code.

This company is:

Service provider

Buffalo, United States

51-100 Employees

Founding year: 2015



Products & services of OmniSeq

Product OmniSeq Offers Differentiating Platform to Clinically Detect Rare Genetic Alterations to Identify Patients Eligible for New, Targeted Therapy for Lung and Thyroid Cancer - OmniSeq image
Product

Verified

OmniSeq Offers Differentiating Platform to Clinically Detect Rare Genetic Alterations to Identify Patients Eligible for New, Targeted Therapy for Lung and Thyroid Cancer - OmniSeq

NGS Test Uses RNA-Sequencing to Detect RET Fusions and DNA-Sequencing to Detect RET Mutations BUFFALO, N.Y., June 29, 2020 /PRNewswire/ — OmniSeq®, an innovator in next generation sequencing (NGS) in oncology, today announced the benefits of its OmniSeq Advance® comprehensive genomic and immune profiling assay to detect the presence of rare alterations in the RET […]

Product SVP Corporate Strategy and Business Development Archives - OmniSeq image
Service

Verified

SVP Corporate Strategy and Business Development Archives - OmniSeq

Chris Drescher | Follow Us on Twitter

View all products


Keywords

Biopharma
Biotechnology
Clinical Trials
Health Care
Health Diagnostics

Industries

Biotechnology

Contact of OmniSeq

City: Buffalo

State: New York

Country: United States



Frequently asked questions (FAQ) about OmniSeq

The company OmniSeq is located in Buffalo, New York, United States. It's worth noting that the company may has more corporate locations

As of the latest available information OmniSeq has around 51-100 employees worldwide.

OmniSeq was founded in 2015

The company OmniSeq has it's main focus in the industries of Biotechnology

Based on the founding year and the amount of employees the company OmniSeq seems to be a Medium-Sized Company at the current state. Note that over time that status can change

Competitors of OmniSeq

Oncologica UK Logo

Oncologica UK

United Kingdom

51-100 Employees

2014

View

Pangaea Oncology Logo

Pangaea Oncology

Spain

View

Ashion Analytics Logo

Ashion Analytics

United States

11-50 Employees

2014

View

Ontada Logo

Ontada

501-1000 Employees

View

TME Breast Care Network Logo

TME Breast Care Network

United States

1-10 Employees

2012

View

OncoCDx | Artificial Intelligence for Personalized Medicine Logo

OncoCDx | Artificial Intelligence for Personalized Medicine

United Kingdom

11-50 Employees

2018

View

NeoGenomics Logo

NeoGenomics

United States

501-1000 Employees

2002

View

Sysmex Inostics Logo

Sysmex Inostics

Germany

51-100 Employees

2008

View


Suitable topics for OmniSeq

Topics which have been searched by others and may be interesting for you: